227 related articles for article (PubMed ID: 11364629)
1. Pouncing on the chemokine receptor Chimera.
Mascolini M
J Int Assoc Physicians AIDS Care; 1997 Aug; 3(8):13-24. PubMed ID: 11364629
[TBL] [Abstract][Full Text] [Related]
2. [Chemokine receptors and its importance in the replication cycle of human immunodeficiency virus: clinical and therapeutic implications].
Azevedo-Pereira JM; Santos-Costa Q
Acta Med Port; 2008; 21(5):497-504. PubMed ID: 19187693
[TBL] [Abstract][Full Text] [Related]
3. HIV chemokine receptor inhibitors as novel anti-HIV drugs.
Princen K; Schols D
Cytokine Growth Factor Rev; 2005 Dec; 16(6):659-77. PubMed ID: 16005254
[TBL] [Abstract][Full Text] [Related]
4. How far can you knock down HIV? An interview with David D. Ho, MD. Interview by Mark Mascolini.
Ho DD
J Int Assoc Physicians AIDS Care; 1997 Jun; 3(6):40-4. PubMed ID: 11364429
[TBL] [Abstract][Full Text] [Related]
5. CXCR4 and CCR5 regulation and expression patterns on T- and monocyte-macrophage cell lineages: implications for susceptibility to infection by HIV-1.
Joly M; Pinto JM
Math Biosci; 2005 May; 195(1):92-126. PubMed ID: 15893340
[TBL] [Abstract][Full Text] [Related]
6. Progesterone-induced inhibition of chemokine receptor expression on peripheral blood mononuclear cells correlates with reduced HIV-1 infectability in vitro.
Vassiliadou N; Tucker L; Anderson DJ
J Immunol; 1999 Jun; 162(12):7510-8. PubMed ID: 10358206
[TBL] [Abstract][Full Text] [Related]
7. Roles of chemokines and chemokine receptors in HIV-1 infection.
Murakami T; Yamamoto N
Int J Hematol; 2000 Dec; 72(4):412-7. PubMed ID: 11197206
[TBL] [Abstract][Full Text] [Related]
8. CCR5 antagonists: a new tool in fighting HIV.
Jülg B; Goebel FD
J HIV Ther; 2005 Dec; 10(4):68-71. PubMed ID: 16519245
[TBL] [Abstract][Full Text] [Related]
9. Chemokine (C-C motif) receptor 5-using envelopes predominate in dual/mixed-tropic HIV from the plasma of drug-naive individuals.
Irlbeck DM; Amrine-Madsen H; Kitrinos KM; Labranche CC; Demarest JF
AIDS; 2008 Jul; 22(12):1425-31. PubMed ID: 18614865
[TBL] [Abstract][Full Text] [Related]
10. Genotypic coreceptor analysis.
Sierra S; Kaiser R; Thielen A; Lengauer T
Eur J Med Res; 2007 Oct; 12(9):453-62. PubMed ID: 17933727
[TBL] [Abstract][Full Text] [Related]
11. [Chemokine receptors and HIV-1 infection].
Hieshima K; Yoshie O
Nihon Rinsho; 2002 Apr; 60(4):681-7. PubMed ID: 11968773
[TBL] [Abstract][Full Text] [Related]
12. [Role of chemokines in the HIV infection process].
Proost P; Schols D
Verh K Acad Geneeskd Belg; 2002; 64(6):403-20. PubMed ID: 12649932
[TBL] [Abstract][Full Text] [Related]
13. Chemokines and chemokine receptors in HIV infection: role in pathogenesis and therapeutics.
Suresh P; Wanchu A
J Postgrad Med; 2006; 52(3):210-7. PubMed ID: 16855325
[TBL] [Abstract][Full Text] [Related]
14. Coreceptor usage by HIV-1 and HIV-2 primary isolates: the relevance of CCR8 chemokine receptor as an alternative coreceptor.
Calado M; Matoso P; Santos-Costa Q; Espirito-Santo M; Machado J; Rosado L; Antunes F; Mansinho K; Lopes MM; Maltez F; Santos-Ferreira MO; Azevedo-Pereira JM
Virology; 2010 Dec; 408(2):174-82. PubMed ID: 20947116
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of CCR5-mediated infection by diverse R5 and R5X4 HIV and SIV isolates using novel small molecule inhibitors of CCR5: effects of viral diversity, target cell and receptor density.
Willey S; Peters PJ; Sullivan WM; Dorr P; Perros M; Clapham PR
Antiviral Res; 2005 Nov; 68(2):96-108. PubMed ID: 16157392
[TBL] [Abstract][Full Text] [Related]
16. Viral evolution in macaques coinfected with CCR5- and CXCR4-tropic SHIVs in the presence or absence of vaccine-elicited anti-CCR5 SHIV neutralizing antibodies.
Burke B; Derby NR; Kraft Z; Saunders CJ; Dai C; Llewellyn N; Zharkikh I; Vojtech L; Zhu T; Srivastava IK; Barnett SW; Stamatatos L
Virology; 2006 Nov; 355(2):138-51. PubMed ID: 16920175
[TBL] [Abstract][Full Text] [Related]
17. Suppression of CCR5- but not CXCR4-tropic HIV-1 in lymphoid tissue by human herpesvirus 6.
Grivel JC; Ito Y; Fagà G; Santoro F; Shaheen F; Malnati MS; Fitzgerald W; Lusso P; Margolis L
Nat Med; 2001 Nov; 7(11):1232-5. PubMed ID: 11689888
[TBL] [Abstract][Full Text] [Related]
18. HIV type 1 chemokine coreceptor use among antiretroviral-experienced patients screened for a clinical trial of a CCR5 inhibitor: AIDS Clinical Trial Group A5211.
Wilkin TJ; Su Z; Kuritzkes DR; Hughes M; Flexner C; Gross R; Coakley E; Greaves W; Godfrey C; Skolnik PR; Timpone J; Rodriguez B; Gulick RM
Clin Infect Dis; 2007 Feb; 44(4):591-5. PubMed ID: 17243065
[TBL] [Abstract][Full Text] [Related]
19. Tropism switch in patients infected with HIV-1 and its clinical implications for the treatment with CCR5-receptor inhibitors.
Arastéh K; Stocker H
Eur J Med Res; 2007 Oct; 12(9):397-402. PubMed ID: 17933720
[TBL] [Abstract][Full Text] [Related]
20. Prospects of HIV-1 entry inhibitors as novel therapeutics.
Pierson TC; Doms RW; Pöhlmann S
Rev Med Virol; 2004; 14(4):255-70. PubMed ID: 15248253
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
